IP Library › Granted Patent US 8,642,332
Granted Patent B2
US 8,642,332 · App. 10/793,640 · Granted Feb 4, 2014

Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain

Inventors: Steven A. Goldman (Webster, NY); Neeta Singh Roy (New York, NY)
Assignee: Cornell Research Foundation, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,642,332
App. No.
10/793,640
Granted
Feb 4, 2014
Kind
B2
Abstract

The present invention is directed to a method of producing neuronal progenitor cells by providing an isolated population of progenitor cells from human brain white matter and permitting the isolated population of cells to differentiate to neuronal progenitor cells. Alternatively, neuronal progenitor cells can be produced by providing an isolated population of glial progenitor cells and permitting the isolated population of glial progenitor cells to differentiate to neuronal progenitor cells.

Claims (10)

1. A method of producing neuronal progenitor cells comprising:

dissecting primarily white matter from adult human brain tissue;

isolating a population of neural progenitor cells from the dissected adult human brain tissue white matter, said isolating comprising immunoseparating the human white matter progenitor cells by extracting cells expressing immunoreactivity for A2B5;

permitting the isolated population of neural progenitor cells from the dissected adult human brain tissue white matter to differentiate to neuronal progenitor cells, in the presence of one or more growth factors; and

recovering an enriched population of neuronal progenitor cells after said permitting the isolated population of neural progenitor cells from the dissected adult human brain tissue white matter to differentiate to neuronal progenitor cells.

2. The method according to claim 1 , wherein the one or more growth factors are selected from the group consisting of basic fibroblast growth factor, platelet-derived growth factor, neurotrophin-3, and combinations thereof.

3. The method according to claim 1 , wherein said immunoseparating is carried out with a fluorescently labeled antibody which recognizes the A2B5 antigen on the human white matter progenitor cells.

4. The method according to claim 3 , wherein said immunoseparating human white matter progenitor cells further comprises:

fluorescence activated cell sorting.

5. The method of claim 1 , wherein said dissecting is carried out so that the dissected white matter is free of adjacent cortex and epithelium.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 15, 2008
From: CORNELL UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021397/0823 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2004
From: GOLDMAN, STEVEN A.; ROY, NEETA SINGH
To: CORNELL RESEARCH FOUNDATION, INC.
Reel/Frame 015674/0157 →
Continuity (2)
Provisional Application 60453280 · Mar 7, 2003
Related Publication 20040253719A1 · Dec 16, 2004